Determining the Prevalence of Upper and Lower Urinary Tract Infections’ Pathogens and Their Antibiotic Susceptibility Profile for Adult Patients in Al-Diwaniya, Iraq (Conference Paper) #
DOI:
https://doi.org/10.31351/vol31issSuppl.pp86-91Keywords:
Urinary tract, UTI, uropathogen, antimicrobial susceptibility, IraqAbstract
Until today, one of the leading predominant infections is Urinary tract infection (UTI). It exerts a huge burden on health systems worldwide each year. Treating UTIs empirically with antimicrobials improves morbidity rates. This study aims to assess the prevalence of UTI-associated bacteria in adult patients and to determine their antibiotic susceptibility profile. A retrospective study was conducted for adult outpatients who visited Al-Diwaniya tertiary hospitals from January 2020 till February 2022 to review their medical and lab records in addition to sociodemographic data. A total of 256 patients’ records were included of which 204 (79.7%) belong to females and 52 (20.3%) were males with an average age of 39.22±17.10 years. The predominant organisms’ isolates were Staphylococcus spp. found in 100 records (39.1%), Escherichia coli (E. coli) demonstrated in 90 records (35.2%), and Klebsiella spp. (K. spp.) revealed in 23 records (9%). Staphylococcus spp. (Staph. spp.) showed high resistance to ampicillin (92.9%) followed by ceftazidime (87.5%), and were highly sensitive to vancomycin. The higher resistance profile of E. coli was to ampicillin (97.9%) and ceftriaxone (81.3%) while was highly susceptible to meropenem (97.9%) and amikacin (97.6%). Additionally, Klebsiella spp. was highly susceptible to nitrofurantoin (78.6%), while was completely resistant to ampicillin. This study presents Staphylococcus spp. as the most prevalent gram-positive uropathogen and E. coli as the most prevalent gram-negative bacteria with a multidrug resistance profile to commonly used antimicrobials which is an alarming situation to implement an immediate effective stewardship program.
References
Ronald AR, Nicolle LE, Stamm E, Krieger J, Warren J, Schaeffer A, et al. Urinary tract infection in adults: research priorities and strategies. Int J Antimicrob Agents. 2001;17(4):343–8.
Zeng Z, Zhan J, Zhang K, Chen H, Cheng S. Global, regional, and national burden of urinary tract infections from 1990 to 2019: an analysis of the global burden of disease study 2019. World J Urol. 2022;40(3):755–63.
Khoshbakht R, Salimi A, Shirzad Aski H, Keshavarzi H. Antibiotic Susceptibility of Bacterial Strains Isolated From Urinary Tract Infections in Karaj, Iran. Jundishapur J Microbiol. 2012;6(1):86–90.
Magliano E, Grazioli V, Deflorio L, Leuci AI, Mattina R, Romano P, et al. Gender and age-dependent etiology of community-acquired urinary tract infections. Scientific World Journal . 2012;2012:349597.
Ronald A. The etiology of urinary tract infection: Traditional and emerging pathogens. Disease-a-Month. 2003;49(2):71–82.
Tandogdu Z, Wagenlehner FME. Global epidemiology of urinary tract infections. Curr Opin Infect Dis. 2016;29(1):73–9.
Abdulrahman IS. Antimicrobial Susceptibility Pattern of Pathogenic Bacteria Causing Urinary Tract Infections at Azadi Hospital In Duhok CityKurdistan Region of Iraq. Sci J Univ Zakho. 2018;6(2):46–50.
Al-Tulaibawi NAJ. Prevalence and sensitivity of bacterial urinary tract infection among adult diabetic patients in misan province, Iraq. J Pure Appl Microbiol. 2019;13(2):847–953.
Mohamed KG, Aljanaby AAJ. Urinary tract infections in Al-Kufa City Iraq and phenotypic detection of antimicrobial sensitivity pattern of bacterial isolates. Int J Pharm Res. 2020;12(1):1454–8.
Naqid IA, Balatay AA, Hussein NR, Ahmed HA, Saeed KA, Abdi SA. Bacterial strains and antimicrobial susceptibility patterns in male urinary tract infections in Duhok Province, Iraq. Middle East J Rehabil Heal Stud. 2020 Jul 13;7(3):1–6.
De Francesco MA, Ravizzola G, Peroni L, Negrini R, Manca N. Urinary tract infections in Brescia, Italy: etiology of uropathogens and antimicrobial resistance of common uropathogens. Med Sci Monit Int Med J Exp Clin Res. 2007 Jun;13(6):BR136-44.
Emiru T, Beyene G, Tsegaye W, Melaku S. Associated risk factors of urinary tract infection among pregnant women at Felege Hiwot Referral Hospital, Bahir Dar, North West Ethiopia. BMC Res Notes. 2013 Jul;6:292.
Laupland KB, Ross T, Pitout JDD, Church DL, Gregson DB. Community-onset urinary tract infections: A population-based assessment. Infection. 2007;35(3):150.
Sharifian M, Karimi A, Tabatabaei SR, Anvaripour N. Microbial sensitivity pattern in urinary tract infections in children: a single center experience of 1,177 urine cultures. Jpn J Infect Dis. 2006 Dec;59(6):380–2.
Idrees MM, Rasool MF, Imran I, Khalid A, Saeed A, Ahmad T, et al. A Cross-Sectional Study to Evaluate antimicrobial susceptibility of uropathogens from South Punjab, Pakistan. Infect Drug Resist. 2022;15(April):1845–55.
Vakilzadeh MM, Heidari A, Mehri A, Shirazinia M, Sheybani F, Aryan E, et al. Antimicrobial resistance among community-acquired uropathogens in Mashhad, Iran. J Environ Public Health. 2020;2020:3439497.
Wanja F, Ngugi C, Omwenga E, Maina J, Kiiru J. Urinary Tract Infection among adults seeking medicare at kiambu level 5 hospital, kenya: prevalence, diversity, antimicrobial susceptibility profiles and possible risk factors. Adv Microbiol. 2021;11(08):360–83.
Sultana M, Alam SKS. Prevalence of bacterial isolates specimens from suspected patients of urinary tract infection in both outpatient department and in patient. Sch J Appl Med Sci. 2021;6691(10):1553–8.
Marwa Ibrahim, Haval Mohammed Khalid, Wijdan M S Mer. The prevalence of uropathogenic escherichia coli strains among outpatients with urinary tract infection in Zakho Hospitals-Zakho City, Duhok Province/ Iraq. Al-Qadisiyah J Pure Sci. 2021;26(5):26–40.
Al-Badr A, Al-Shaikh G. Recurrent urinary tract infections management in women: A review. Sultan Qaboos Univ Med J. 2013;13(3):359–67.
Tan CW, Chlebicki MP. Urinary tract infections in adults. Singapore Med J. 2016;57(9):485–90.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512)
This work is licensed under a Creative Commons Attribution 4.0 International License.
